Fatal avian influenza (H5N1) infection in human, China

Emerging Infectious Diseases

Volumn 16, Issue 11, 2010, Pages 1799-1801

  Zhang, Ji ^a   Geng, Xingyi ^a   Ma, Yanhui ^a   Ruan, Shiman ^a   Xu, Shuhui ^a   Liu, Lanzheng ^a   Xu, Huaru ^a   Yang, Guoliang ^a   Wang, Chunrong ^a   Liu, Chong ^a   Han, Xiuyun ^a   Yu, Qiuyan ^a   Cheng, Hongqi ^a   Li, Zhan ^a  

^a Jinan Center for Disease Control and Prevention   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; CEPHALOSPORIN DERIVATIVE; INFLUENZA VIRUS HEMAGGLUTININ; OSELTAMIVIR; RIBAVIRIN; VIRUS SIALIDASE;

ADULT RESPIRATORY DISTRESS SYNDROME; CHINA; EARLY INTERVENTION; FATALITY; FEVER; FLU LIKE SYNDROME; HUMAN; INFLUENZA; INFLUENZA A (H5N1); INFLUENZA VIRUS A H5N1; LETTER; LUNG INFILTRATE; MULTIPLE ORGAN FAILURE; NONHUMAN; PANDEMIC INFLUENZA; PNEUMONIA; POULTRY FARMING; RESPIRATORY TRACT DISEASE; SYMPTOM; THROAT CULTURE; VIRAL CONTAMINATION; VIREMIA; VIRUS CULTURE; VIRUS REPLICATION; VIRUS RESISTANCE; VIRUS TRANSMISSION;

ADULT; ANIMALS; ANTIVIRAL AGENTS; BIRDS; FATAL OUTCOME; FEMALE; GENOME, VIRAL; HUMANS; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA, HUMAN; MULTIPLE ORGAN FAILURE; RESPIRATORY DISTRESS SYNDROME, ADULT; RIBAVIRIN;

EID: 77958544883     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1611.090212     Document Type: Letter

References (10)

1. World Health Organization. H5N1 avian influenza: timeline of major events [cited 2009 Feb 8]. http://www.who.int/csr/disease/avian_influenza/Timeline_09_01_21.pdf
2. Wang H, Feng Z, Shu Y, Yu H, Zhou L, Zu R, et al. Probable limited person-to-person transmission of highly pathogenic avian influenza A (H5N1) virus in China. Lan-cet. 2008;371:1427-34. DOI: 10.1016/S0140-6736(08)60493-6
3. World Health Organization. Epidemic and pandemic alert and response (EPR): avian influenza- situation in China-update [cited 2009 Feb 8]. http://www.who.int/csr/don/2009_01_19/en/
4. Wang MZ, Tai CY, Mendel DB. Mecha-nism by which mutations at his274 al-ter sensitivity of influenza A virus N1 neuraminidase to oseltamivir carboxy-late and zanamivir. Antimicrob Agents Chemother. 2002;46:3809-16. DOI:10.1128/AAC.46.12.3809-3816.2002
5. Suzuki H, Saito R, Masuda H, Oshitani H, Sato M, Sato I. Emergence of amantadine-esistant influenza A viruses: epidemiological study. J Infect Chemother. 2003;9:195-200. DOI: 10.1007/s10156-003-0262-6
6. Kawachi S, Luong ST, Shigematsu M, Furuya H, Phung TT, Phan PH, et al. Risk parameters of fulminant acute respiratory distress syndrome and avian influenza (H5N1) infection in Vietnamese children. J Infect Dis. 2009;200:510-5. DOI:10.1086/605034
7. Kandun IN, Tresnaningsih E, Purba WH, Lee V, Samaan G, Harun S, et al. Factors associated with case fatality of human H5N1 virus infections in Indonesia: a case series. Lancet. 2008;372:744-9. DOI:10.1016/S0140-6736(08)61125-3
8. World Health Organization. China reports second confirmed case of influenza A(H1N1) [cited 2010 Jul 20]. http://www.wpro.who.int/media_centre/news/news_20090513.htm
9. Shinya K, Ebina M, Yamada S, Ono M, Kasai N, Kawaoka Y. Avian flu: influenza virus receptors in the human airway. Nature. 2006;440:435-6. DOI: 10.1038/440435a
10. Smith JR. Oseltamivir in human avian influenza infection. J Antimicrob Chemother. 2010; 65:Suppl 2:ii25-ii33.